Galina Glazko
Concepts (315)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 16 | 2019 | 214 | 2.810 |
Why?
| Gene Expression Profiling | 15 | 2021 | 1031 | 1.950 |
Why?
| Gene Regulatory Networks | 7 | 2019 | 107 | 1.770 |
Why?
| Databases, Genetic | 8 | 2017 | 88 | 1.510 |
Why?
| Evolution, Molecular | 10 | 2012 | 99 | 1.490 |
Why?
| Transcriptome | 6 | 2021 | 313 | 1.420 |
Why?
| Colonic Neoplasms | 3 | 2019 | 162 | 1.250 |
Why?
| RNA | 4 | 2016 | 170 | 1.190 |
Why?
| Sequence Analysis, RNA | 6 | 2019 | 91 | 0.950 |
Why?
| DNA | 9 | 2013 | 545 | 0.930 |
Why?
| Gene Expression | 6 | 2022 | 608 | 0.930 |
Why?
| Proteome | 3 | 2021 | 173 | 0.920 |
Why?
| Oligonucleotide Array Sequence Analysis | 10 | 2017 | 412 | 0.920 |
Why?
| Phylogeny | 9 | 2010 | 230 | 0.810 |
Why?
| Genes, p53 | 4 | 2013 | 51 | 0.780 |
Why?
| Systems Biology | 2 | 2011 | 33 | 0.750 |
Why?
| Signal Transduction | 5 | 2019 | 1617 | 0.710 |
Why?
| Genes, Neoplasm | 1 | 2019 | 30 | 0.680 |
Why?
| Software | 5 | 2017 | 273 | 0.660 |
Why?
| Consensus | 1 | 2019 | 143 | 0.640 |
Why?
| Nuclear Matrix | 4 | 2003 | 6 | 0.640 |
Why?
| Colonic Polyps | 1 | 2017 | 36 | 0.600 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 169 | 0.590 |
Why?
| Adenoma | 1 | 2017 | 110 | 0.550 |
Why?
| Models, Genetic | 7 | 2008 | 174 | 0.550 |
Why?
| Computer Simulation | 6 | 2017 | 282 | 0.510 |
Why?
| Genes, X-Linked | 1 | 2014 | 7 | 0.500 |
Why?
| Genetic Variation | 4 | 2009 | 214 | 0.480 |
Why?
| Proteins | 4 | 2014 | 341 | 0.430 |
Why?
| Primates | 2 | 2003 | 20 | 0.430 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2012 | 47 | 0.420 |
Why?
| Models, Statistical | 3 | 2012 | 225 | 0.420 |
Why?
| Tumor Suppressor Protein p53 | 3 | 2017 | 202 | 0.410 |
Why?
| Animals | 25 | 2021 | 13150 | 0.410 |
Why?
| Phenotype | 5 | 2017 | 727 | 0.390 |
Why?
| Disease | 1 | 2011 | 25 | 0.390 |
Why?
| Humans | 36 | 2023 | 49827 | 0.380 |
Why?
| Genome, Viral | 3 | 2008 | 79 | 0.380 |
Why?
| Azospirillum brasilense | 2 | 2022 | 4 | 0.380 |
Why?
| Bacteriophages | 2 | 2007 | 8 | 0.380 |
Why?
| Algorithms | 4 | 2017 | 616 | 0.360 |
Why?
| Base Sequence | 9 | 2013 | 650 | 0.360 |
Why?
| Genome | 3 | 2013 | 67 | 0.340 |
Why?
| Gene Expression Regulation | 6 | 2017 | 979 | 0.340 |
Why?
| Neoplasms | 3 | 2005 | 1233 | 0.330 |
Why?
| Principal Component Analysis | 2 | 2019 | 55 | 0.320 |
Why?
| Proteomics | 3 | 2021 | 328 | 0.310 |
Why?
| Molecular Sequence Data | 8 | 2012 | 797 | 0.300 |
Why?
| Biological Evolution | 2 | 2023 | 32 | 0.300 |
Why?
| Germ-Line Mutation | 3 | 2005 | 61 | 0.290 |
Why?
| Cluster Analysis | 4 | 2017 | 235 | 0.280 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 168 | 0.280 |
Why?
| Chromosome Mapping | 2 | 2008 | 160 | 0.270 |
Why?
| Linkage Disequilibrium | 1 | 2005 | 37 | 0.270 |
Why?
| Time | 2 | 2003 | 25 | 0.260 |
Why?
| Multivariate Analysis | 3 | 2017 | 585 | 0.250 |
Why?
| Binding Sites | 4 | 2012 | 377 | 0.240 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 829 | 0.240 |
Why?
| Chromosomes | 2 | 2008 | 33 | 0.240 |
Why?
| Nucleotides | 3 | 2023 | 23 | 0.230 |
Why?
| Mammals | 3 | 2002 | 56 | 0.230 |
Why?
| Sequence Analysis, DNA | 5 | 2007 | 237 | 0.230 |
Why?
| DNA, Intergenic | 1 | 2003 | 7 | 0.220 |
Why?
| Mutation | 5 | 2019 | 1293 | 0.220 |
Why?
| Conserved Sequence | 1 | 2003 | 56 | 0.220 |
Why?
| Genomics | 3 | 2017 | 282 | 0.210 |
Why?
| Cecum | 2 | 2021 | 63 | 0.210 |
Why?
| Herbaspirillum | 1 | 2022 | 2 | 0.210 |
Why?
| RNA, Messenger | 4 | 2019 | 1105 | 0.210 |
Why?
| Cell Cycle Proteins | 2 | 2017 | 166 | 0.200 |
Why?
| Cell Line, Tumor | 2 | 2017 | 1402 | 0.190 |
Why?
| Selection, Genetic | 3 | 2012 | 24 | 0.180 |
Why?
| Reproducibility of Results | 4 | 2016 | 1188 | 0.180 |
Why?
| Cell Nucleus | 2 | 2013 | 184 | 0.180 |
Why?
| Infant Formula | 1 | 2021 | 145 | 0.180 |
Why?
| RNA, Untranslated | 1 | 2019 | 14 | 0.170 |
Why?
| Sequence Alignment | 4 | 2007 | 121 | 0.170 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2013 | 55 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 8 | 0.170 |
Why?
| Drosophila melanogaster | 2 | 2012 | 30 | 0.160 |
Why?
| Phosphoproteins | 2 | 2013 | 113 | 0.160 |
Why?
| Extracellular Matrix | 1 | 2019 | 111 | 0.160 |
Why?
| Starch | 1 | 2019 | 28 | 0.160 |
Why?
| Profilins | 1 | 2018 | 16 | 0.160 |
Why?
| Sample Size | 2 | 2015 | 37 | 0.160 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 39 | 0.160 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 34 | 0.150 |
Why?
| Nuclear Proteins | 3 | 2006 | 243 | 0.150 |
Why?
| Pharmacogenetics | 1 | 2018 | 52 | 0.150 |
Why?
| Hyperplasia | 1 | 2017 | 99 | 0.150 |
Why?
| Small Molecule Libraries | 1 | 2018 | 68 | 0.150 |
Why?
| GTP-Binding Proteins | 1 | 2017 | 90 | 0.150 |
Why?
| Chromatin | 2 | 2012 | 152 | 0.150 |
Why?
| Diet | 1 | 2021 | 564 | 0.150 |
Why?
| Neurodegenerative Diseases | 1 | 2018 | 76 | 0.150 |
Why?
| Gene Amplification | 1 | 1997 | 57 | 0.150 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 88 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 142 | 0.140 |
Why?
| DNA Replication | 2 | 2016 | 151 | 0.140 |
Why?
| Lampreys | 2 | 2007 | 2 | 0.140 |
Why?
| DNA Helicases | 2 | 2016 | 142 | 0.140 |
Why?
| Data Mining | 1 | 2017 | 40 | 0.140 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 124 | 0.140 |
Why?
| Down-Regulation | 1 | 2017 | 349 | 0.140 |
Why?
| Colorectal Neoplasms | 1 | 2019 | 234 | 0.140 |
Why?
| Protein Interaction Maps | 1 | 2016 | 23 | 0.140 |
Why?
| Protein Processing, Post-Translational | 1 | 2017 | 171 | 0.140 |
Why?
| Kidney | 1 | 2020 | 665 | 0.130 |
Why?
| Up-Regulation | 1 | 2017 | 450 | 0.130 |
Why?
| Protein Interaction Mapping | 1 | 2016 | 40 | 0.130 |
Why?
| Models, Theoretical | 1 | 2017 | 174 | 0.130 |
Why?
| Mice | 5 | 2020 | 5720 | 0.130 |
Why?
| Bacterial Proteins | 1 | 2019 | 373 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 2017 | 323 | 0.130 |
Why?
| Breast Neoplasms | 3 | 2021 | 1169 | 0.120 |
Why?
| Data Interpretation, Statistical | 2 | 2013 | 157 | 0.120 |
Why?
| Likelihood Functions | 2 | 2005 | 54 | 0.120 |
Why?
| Lymphocytes | 1 | 2014 | 151 | 0.120 |
Why?
| Fossils | 2 | 2005 | 19 | 0.120 |
Why?
| Adaptation, Physiological | 2 | 2012 | 91 | 0.110 |
Why?
| Lung Neoplasms | 1 | 2019 | 605 | 0.110 |
Why?
| Activating Transcription Factor 1 | 1 | 2013 | 22 | 0.110 |
Why?
| RNA Stability | 1 | 2013 | 24 | 0.110 |
Why?
| RNA, Fungal | 1 | 2013 | 21 | 0.110 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2013 | 39 | 0.110 |
Why?
| RNA, Antisense | 1 | 2012 | 6 | 0.110 |
Why?
| Schizosaccharomyces | 1 | 2013 | 54 | 0.110 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 118 | 0.110 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 8 | 0.110 |
Why?
| RNA, Double-Stranded | 1 | 2012 | 21 | 0.110 |
Why?
| Ribosomal Proteins | 1 | 2012 | 25 | 0.110 |
Why?
| Genomic Instability | 1 | 2013 | 92 | 0.110 |
Why?
| Tunica Intima | 1 | 2012 | 55 | 0.100 |
Why?
| Amino Acid Sequence | 4 | 2008 | 587 | 0.100 |
Why?
| Carotid Arteries | 1 | 2012 | 85 | 0.100 |
Why?
| Genes | 2 | 2004 | 34 | 0.100 |
Why?
| Disease Progression | 3 | 2020 | 822 | 0.100 |
Why?
| Chromosome Disorders | 1 | 2012 | 35 | 0.100 |
Why?
| Rats | 3 | 2019 | 3300 | 0.100 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 131 | 0.100 |
Why?
| G-Quadruplexes | 1 | 2013 | 80 | 0.100 |
Why?
| Species Specificity | 2 | 2005 | 193 | 0.100 |
Why?
| Open Reading Frames | 3 | 2023 | 54 | 0.100 |
Why?
| Protein Array Analysis | 1 | 2010 | 23 | 0.100 |
Why?
| Gene Transfer, Horizontal | 2 | 2007 | 7 | 0.090 |
Why?
| Plant Roots | 2 | 2022 | 34 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2003 | 49 | 0.090 |
Why?
| Saccharomyces cerevisiae | 2 | 2013 | 192 | 0.090 |
Why?
| Ethanol | 1 | 2012 | 338 | 0.090 |
Why?
| Bacteria | 2 | 2021 | 223 | 0.080 |
Why?
| Periodicity | 1 | 2008 | 24 | 0.080 |
Why?
| Male | 8 | 2020 | 25093 | 0.080 |
Why?
| Cell Proliferation | 1 | 2012 | 1007 | 0.080 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2008 | 70 | 0.080 |
Why?
| Thermus thermophilus | 1 | 2008 | 1 | 0.080 |
Why?
| Siphoviridae | 1 | 2008 | 1 | 0.080 |
Why?
| Bayes Theorem | 2 | 2012 | 108 | 0.080 |
Why?
| Flow Cytometry | 1 | 2010 | 470 | 0.080 |
Why?
| Viral Proteins | 2 | 2008 | 155 | 0.080 |
Why?
| Cytosine Deaminase | 1 | 2007 | 8 | 0.070 |
Why?
| Receptors, Antigen | 1 | 2007 | 2 | 0.070 |
Why?
| DNA, Viral | 1 | 2008 | 133 | 0.070 |
Why?
| Amino Acid Substitution | 2 | 2004 | 82 | 0.070 |
Why?
| Globins | 3 | 2003 | 14 | 0.070 |
Why?
| Aryldialkylphosphatase | 1 | 2007 | 4 | 0.070 |
Why?
| Nuclear Envelope | 1 | 2006 | 4 | 0.070 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2007 | 78 | 0.070 |
Why?
| Adaptation, Biological | 1 | 2005 | 10 | 0.070 |
Why?
| 5' Untranslated Regions | 2 | 2003 | 31 | 0.070 |
Why?
| Receptors, Immunologic | 1 | 2005 | 37 | 0.070 |
Why?
| Immunity | 1 | 2005 | 36 | 0.070 |
Why?
| Plants | 2 | 2002 | 27 | 0.070 |
Why?
| Pan troglodytes | 1 | 2005 | 11 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2011 | 467 | 0.060 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 54 | 0.060 |
Why?
| Hominidae | 1 | 2005 | 18 | 0.060 |
Why?
| Calibration | 1 | 2005 | 58 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 155 | 0.060 |
Why?
| DNA, Neoplasm | 1 | 2005 | 147 | 0.060 |
Why?
| Mutation, Missense | 1 | 2005 | 103 | 0.060 |
Why?
| Gene Expression Regulation, Archaeal | 1 | 2004 | 1 | 0.060 |
Why?
| Genes, Archaeal | 1 | 2004 | 3 | 0.060 |
Why?
| Chickens | 1 | 2005 | 106 | 0.060 |
Why?
| Eukaryotic Cells | 1 | 2004 | 17 | 0.060 |
Why?
| Genes, Fungal | 1 | 2004 | 35 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2004 | 73 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2020 | 1451 | 0.060 |
Why?
| Octopamine | 1 | 2004 | 1 | 0.060 |
Why?
| Inheritance Patterns | 1 | 2004 | 22 | 0.060 |
Why?
| Statistics as Topic | 1 | 2004 | 89 | 0.060 |
Why?
| Genes, Bacterial | 1 | 2004 | 62 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2007 | 485 | 0.060 |
Why?
| CpG Islands | 1 | 2004 | 107 | 0.060 |
Why?
| Membrane Proteins | 1 | 2006 | 342 | 0.060 |
Why?
| Quality Control | 1 | 2004 | 94 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2004 | 127 | 0.060 |
Why?
| Trans-Activators | 1 | 2004 | 134 | 0.060 |
Why?
| DNA Topoisomerases, Type I | 1 | 2003 | 2 | 0.060 |
Why?
| DNA Topoisomerases, Type II | 1 | 2003 | 16 | 0.060 |
Why?
| Genome, Bacterial | 1 | 2004 | 125 | 0.060 |
Why?
| Female | 5 | 2021 | 26329 | 0.050 |
Why?
| Myocardial Infarction | 1 | 2007 | 382 | 0.050 |
Why?
| Dopamine | 1 | 2004 | 171 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2003 | 107 | 0.050 |
Why?
| Protein Binding | 2 | 2006 | 660 | 0.050 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2004 | 188 | 0.050 |
Why?
| Immunoglobulins | 1 | 2003 | 79 | 0.050 |
Why?
| Vertebrates | 1 | 2002 | 11 | 0.050 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 436 | 0.050 |
Why?
| DNA, Plant | 1 | 2001 | 5 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2007 | 510 | 0.050 |
Why?
| Telomere | 1 | 2001 | 36 | 0.050 |
Why?
| Models, Animal | 1 | 2021 | 233 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 41 | 0.050 |
Why?
| Transcription Factors | 1 | 2004 | 563 | 0.050 |
Why?
| Nucleic Acid Conformation | 2 | 2013 | 85 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 366 | 0.050 |
Why?
| Milk, Human | 1 | 2021 | 109 | 0.050 |
Why?
| Swine | 1 | 2021 | 391 | 0.050 |
Why?
| Decision Trees | 1 | 2019 | 19 | 0.040 |
Why?
| Antigens, Nuclear | 1 | 2000 | 24 | 0.040 |
Why?
| RNA, Plant | 1 | 2019 | 7 | 0.040 |
Why?
| Genes, Plant | 1 | 2019 | 10 | 0.040 |
Why?
| Symbiosis | 1 | 2019 | 10 | 0.040 |
Why?
| Gene Expression Regulation, Plant | 1 | 2019 | 44 | 0.040 |
Why?
| Li-Fraumeni Syndrome | 1 | 1999 | 13 | 0.040 |
Why?
| Exons | 1 | 1999 | 95 | 0.040 |
Why?
| Cell Cycle | 2 | 2012 | 232 | 0.040 |
Why?
| Motor Neurons | 1 | 2018 | 39 | 0.040 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 138 | 0.040 |
Why?
| Neuroglia | 1 | 2018 | 43 | 0.040 |
Why?
| Time Factors | 1 | 2005 | 2912 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 1999 | 465 | 0.040 |
Why?
| Artiodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Perissodactyla | 1 | 1997 | 1 | 0.040 |
Why?
| Electrophoresis, Agar Gel | 1 | 1997 | 12 | 0.040 |
Why?
| Random Amplified Polymorphic DNA Technique | 1 | 1997 | 3 | 0.040 |
Why?
| Spinal Cord | 1 | 2018 | 177 | 0.040 |
Why?
| Protein Isoforms | 1 | 2017 | 119 | 0.040 |
Why?
| DNA Primers | 1 | 1997 | 206 | 0.040 |
Why?
| Genetic Markers | 1 | 1997 | 103 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2000 | 904 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2018 | 555 | 0.040 |
Why?
| Phosphorylation | 1 | 2017 | 536 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 728 | 0.030 |
Why?
| MicroRNAs | 1 | 2019 | 354 | 0.030 |
Why?
| Prognosis | 1 | 2021 | 1952 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 1595 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 664 | 0.030 |
Why?
| DNA Repair | 1 | 2016 | 192 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1002 | 0.030 |
Why?
| Research Design | 1 | 2016 | 343 | 0.030 |
Why?
| Genome, Mitochondrial | 1 | 2013 | 8 | 0.030 |
Why?
| Tunica Media | 1 | 2012 | 10 | 0.030 |
Why?
| G1 Phase | 1 | 2012 | 14 | 0.030 |
Why?
| S Phase | 1 | 2012 | 19 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 81 | 0.030 |
Why?
| Lod Score | 1 | 2012 | 7 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2013 | 71 | 0.030 |
Why?
| Microarray Analysis | 1 | 2012 | 73 | 0.030 |
Why?
| Genes, Insect | 1 | 2012 | 11 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 27 | 0.030 |
Why?
| Larva | 1 | 2012 | 26 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 161 | 0.030 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 91 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2012 | 116 | 0.020 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2003 | 97 | 0.020 |
Why?
| Internet | 1 | 2012 | 261 | 0.020 |
Why?
| Mitochondria | 1 | 2013 | 397 | 0.020 |
Why?
| Prostatic Neoplasms | 1 | 2013 | 396 | 0.020 |
Why?
| Cells, Cultured | 1 | 2012 | 1571 | 0.020 |
Why?
| Virion | 1 | 2008 | 18 | 0.020 |
Why?
| Breast | 1 | 2008 | 85 | 0.020 |
Why?
| DNA, Complementary | 1 | 2008 | 135 | 0.020 |
Why?
| Glioma | 1 | 2008 | 79 | 0.020 |
Why?
| Recombination, Genetic | 1 | 2008 | 108 | 0.020 |
Why?
| Aspartic Acid | 1 | 2007 | 49 | 0.020 |
Why?
| Age of Onset | 1 | 2007 | 106 | 0.020 |
Why?
| Chromosome Segregation | 1 | 2006 | 12 | 0.020 |
Why?
| Centrosome | 1 | 2006 | 11 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 146 | 0.020 |
Why?
| Glutamic Acid | 1 | 2007 | 107 | 0.020 |
Why?
| Spores, Bacterial | 1 | 2005 | 5 | 0.020 |
Why?
| Bacillus subtilis | 1 | 2005 | 5 | 0.020 |
Why?
| Bacillus anthracis | 1 | 2005 | 10 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 253 | 0.020 |
Why?
| Glutamine | 1 | 2007 | 171 | 0.020 |
Why?
| Genotype | 1 | 2007 | 538 | 0.020 |
Why?
| Arginine | 1 | 2007 | 179 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2005 | 74 | 0.020 |
Why?
| Brain Neoplasms | 1 | 2008 | 286 | 0.020 |
Why?
| Tyrosine Decarboxylase | 1 | 2004 | 1 | 0.010 |
Why?
| Hybridization, Genetic | 1 | 2004 | 7 | 0.010 |
Why?
| Heat Stress Disorders | 1 | 2004 | 9 | 0.010 |
Why?
| Locus Control Region | 1 | 2003 | 1 | 0.010 |
Why?
| Terminal Repeat Sequences | 1 | 2003 | 11 | 0.010 |
Why?
| False Positive Reactions | 1 | 2002 | 63 | 0.010 |
Why?
| Trinucleotide Repeats | 1 | 2002 | 4 | 0.010 |
Why?
| Cohort Studies | 1 | 2007 | 1422 | 0.010 |
Why?
| Codon, Initiator | 1 | 2002 | 9 | 0.010 |
Why?
| Genome, Human | 1 | 2003 | 111 | 0.010 |
Why?
| Introns | 1 | 2002 | 49 | 0.010 |
Why?
| Survival Analysis | 1 | 2004 | 659 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 2179 | 0.010 |
Why?
| Sex Factors | 1 | 2004 | 693 | 0.010 |
Why?
| Prospective Studies | 1 | 2007 | 2344 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 477 | 0.010 |
Why?
| Brain | 1 | 2008 | 1309 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2002 | 253 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 41 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2007 | 3125 | 0.010 |
Why?
| Risk Factors | 1 | 2007 | 3619 | 0.010 |
Why?
| Aged | 1 | 2007 | 9272 | 0.010 |
Why?
| Middle Aged | 1 | 2007 | 11997 | 0.010 |
Why?
| Adult | 1 | 2007 | 13160 | 0.010 |
Why?
|
|
Glazko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|